ADMELOG is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Insulin Lispro.
| Product ID | 70518-2399_967b9b62-abe6-f0ab-e053-2995a90a7fd7 |
| NDC | 70518-2399 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ADMELOG |
| Generic Name | Insulin Lispro |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 2019-10-30 |
| Marketing Category | NDA / NDA |
| Application Number | NDA209196 |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | INSULIN LISPRO |
| Active Ingredient Strength | 100 U/mL |
| Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-10-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA209196 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-10-30 |
| Ingredient | Strength |
|---|---|
| INSULIN LISPRO | 100 U/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0024-5924 | ADMELOG | ADMELOG |
| 0024-5926 | ADMELOG | ADMELOG |
| 0024-5925 | ADMELOG | ADMELOG |
| 70518-2399 | ADMELOG | ADMELOG |
| 0002-7510 | Humalog | Insulin lispro |
| 0002-7511 | Humalog | Insulin lispro |
| 0002-7512 | Humalog | Insulin lispro |
| 0002-7516 | Humalog | Insulin lispro |
| 0002-7712 | Humalog | Insulin lispro |
| 0002-7714 | Humalog | Insulin lispro |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ADMELOG 87682668 5475626 Live/Registered |
Sanofi 2017-11-13 |
![]() ADMELOG 86787842 5080517 Live/Registered |
Sanofi 2015-10-14 |